BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has submitted a routine quarterly compliance certificate to NSE for the period April 1 to June 30, 2025. The certificate was issued by Aarthi Consultants Private Limited, the company's Registrar and Share Transfer Agent (RTA). It confirms that the RTA completed all required actions within 15 days of receiving physical share certificates from depository participants. Specifically, the RTA dematerialized the securities, cancelled and mutilated the physical certificates, and updated the depository's name as the registered owner in company records. This is a standard procedural filing required under SEBI's depository regulations and carries no financial or strategic information.
This is a routine regulatory compliance filing with no impact on the company's financials, operations, or shareholder value. Investors can ignore this as background administrative work.